A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Integrative oncology combines standard cancer treatments with complementary therapies to manage symptoms and improve ...

Moderately hypofractionated definitive radiotherapy may be used as a radical treatment option in patients with inoperable non ...

A University of Kentucky Markey Cancer Center study reveals how prostate cancer cells adapt their metabolism to thrive in bone tissue, offering a ...

Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

COFFEE COUNTY, Ga. (WALB) — A Coffee County teenager is leaning on faith and resilience as he continues his battle with stage ...

TLX591-CDx (Illuccix® in approved jurisdictions, 68 Ga-PSMA-11 ): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.

During a live event, Kathryn E. Beckermann, MD, PhD, and participants discussed whether risk stratification factors into the ...

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...